According to the APF, more than 50 EPP patients in the US have already begun treatment or will shortly.
I have two burning questions:
1) When will Clinuvel finally open their US NJ office? It's been advertised as 'opening soon' for well over a year now.
2) When will Clinuvel finally release the full Phase III EPP results? Shareholders were told in the Feb. newsletter and on the website they would be released in Q1. Wolgen said in the Rosacea board interview it would be in March.
Three months overdue is another reason the market is not taking much interest (still) in this company.
us trials update
Add CUV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$13.28 |
Change
-0.250(1.85%) |
Mkt cap ! $664.8M | |||
| Open | High | Low | Value | Volume |
| $13.55 | $13.62 | $13.25 | $1.157M | 86.45K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 227 | $13.28 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $13.42 | 228 | 1 |
View Market Depth
| Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
| CUV (ASX) Chart |